4
Changes in Ownership
Vaxart, Inc. Filed Acc 0001437749-22-009651
SVP, Chief Scientific Officer acquired 40,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tucker Sean SVP, Chief Scientific Officer | 2022-04-22 | Option exercise | +40,000 | $0.77 | $30,800 | 127,631 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Tucker Sean SVP, Chief Scientific Officer | 2022-04-22 | Option exercise · Stock Option (right to buy) | −40,000 | 84,061 | D: show line 2 in the form |
Loading xslF345X03/rdgdoc.xml…